CLOSE
Designed to target solid and liquid tumors
Offers new solution for autoimmune diseases and infection diseases
Potential to treat a broad spectrum of solid tumors, lymphoma and leukemia.
Potential to treat both T cell and B cell mediated autoimmune diseases.
CNK-UT is developed from selected T cells sourced from the healthy donor
Enables industrial-scale production with high quality and low cost
Demonstrated long-term safety and efficacy in liver cancer, neuroblastoma and breast cancer patients
Demonstrated long-term safety and efficacy in treating steroid refractory graft-versus-host disease (GVHD)
Demonstrated long-term safety and efficacy in liver cancer, neuroblastoma and breast cancer patients
Demonstrated long-term safety and efficacy in treating steroid refractory graft-versus-host disease (GVHD)
